My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 9 521 / DOI: 10.3332/ecancer.2015.521

Clinical Study

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent

Itraconazole, a common triazole anti-fungal drug in widespread clinical use, has evidence of clinical activity that is of interest in oncology. There is evidence that at the clinically relevant doses, itraconazole has potent anti-angiogenic activity, and that it can inhibit the Hedgehog signalling pathway and may also induce autophagic growth arrest. The evidence for these anticancer effects, in vitro, in vivo, and clinical are summarised, and the putative mechanisms of their action outlined. Clinical trials have shown that patients with prostate, lung, and basal cell carcinoma have benefited from treatment with itraconazole, and there are additional reports of activity in leukaemia, ovarian, breast, and pancreatic cancers. Given the evidence presented, a case is made that itraconazole warrants further clinical investigation as an anti-cancer agent. Additionally, based on the properties summarised previously, it is proposed that itraconazole may synergise with a range of other drugs to enhance the anti-cancer effect, and some of these possible combinations are presented in the supplementary materials accompanying this paper.

Keywords: Drug repurposing, itraconazole, Hedgehog pathway inhibition, ReDO project

Loading Article Metrics ... Please wait

Related articles

Review: Cancer of childhood in sub-Saharan Africa

Abstract | Full Article | PDF Published: 28 Jul 2017 / DOI: 10.3332/ecancer.2017.755

Case Report: Deterioration of duodenal lymphangiectasia after radiotherapy for gastric MALT lymphoma

Abstract | Full Article | PDF Published: 11 Jul 2017 / DOI: 10.3332/ecancer.2017.752

Research: Brain imaging before primary lung cancer resection: a controversial topic

Abstract | Full Article | PDF Published: 20 Jun 2017 / DOI: 10.3332/ecancer.2017.749

Special Issue: The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

Abstract | Full Article | PDF Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.746

Special Issue: Radioguided localisation of non-palpable lesions of the breast in Costa Rica: Review of results of our first 800 patients in private practice

Abstract | Full Article | PDF | Spanish Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.745



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence